Mahadev M.

Most peptide and GLP-1 brands do not fail because of bad science. They fail because one non-compliant product description kills their merchant account, one ad gets flagged before it goes live, and one affiliate partner walks away because the compliance architecture cannot protect them. By the time they realize the problem, the damage is already done. I fix that. Before it happens. I am a Pharma MBA with a Chemistry degree and 18 years inside the pharmaceutical industry, working at the intersection of peptide science, FDA regulatory compliance, and performance marketing. My clients are US peptide and GLP-1 brands who need someone who understands the molecular science, knows exactly where the FDA and FTC draw the line, and can build the marketing and affiliate infrastructure that survives platform review, payment processor scrutiny, and regulatory enforcement simultaneously. What this looks like in practice: I completed a 101-finding FDA and FTC compliance audit for a US peptide brand, rebuilding their entire content architecture under FDA Objective Intent Doctrine and Google 2026 E-E-A-T guidelines. I diagnosed and reversed a Google Merchant Center suspension for a peptide supplier flagged for Misrepresentation and Healthcare and Medicine violations, tracing the real trigger to an unmoderated content section the suspension notice never named. I architected and deployed a full RUO affiliate program with partner recruitment, compliance framework, and promotional structures that give media buyers room to scale without exposing the brand. I also built and shipped a Shopify app that scans product catalogs for Merchant Center compliance triggers before they become suspensions. My work is narrow by design. Peptides, GLP-1 agonists, longevity compounds, RUO compliance, affiliate architecture, and health marketing for regulated brands. Every molecular claim I produce is verified against PubChem and peer-reviewed literature. Every CAS number is manually cross-referenced. Every compliance recommendation reflects current enforcement, not outdated boilerplate. If your peptide or GLP-1 brand is trying to grow without getting shut down, send me a message. Mahadev Mukherjee Pharma MBA | BSc Chemistry | 18 Years Pharmaceutical Strategy Peptides | GLP-1 | FDA Compliance | Health Marketing